Crane (NYSE:CR) Azioni

CRANE CO

Crane

Crane Holdings

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.

Crane Co

Crabada

C-Rad AB

CRA International Inc

VanEck Oil Refiners ETF

Cal Redwood Acquisition Corp

Credit Agricole SA

CREDIT AGRICOLE UNSP/ADR by Credit Agricole SA

CRAWFORD UNITED CORP by Crawford United Corporation

Crawford United Corp

CRAYON GROUP HLDG AS by Crayon Group HLDG AS

Crayon Group Holding ASA

Carbeeza Inc

CORBY SPIRIT AND WINE B by Corby Spirit and Wine Ltd.

Corby Spirit and Wine Ltd

Corebridge Financial Inc. 6.375% Junior Subordinated Notes due 2064

Corebridge Financial Inc

CHINA RESOURCES LAND LTD by China Resources Land Ltd.

China Resources Land Ltd

CHINA RES LAND UNSP/ADR by China Resources Land Ltd.

Carebook Technologies Inc Ordinary Shares

iShares MSCI ACWI Low Carbon Target ETF

CARBON ENERGY CORP by Carbon Energy Corporation

Carbon Energy Corp

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals Holdings Inc

CARBON TRANSITION ASA by CARBON TRANSITION ASA

Caribou Biosciences Inc

California Resources Corporation Common Stock

California Resources Corp

CHONGQUING RURAL COML BK by Chongquing Rural Commercial Bank Co Ltd.

Chongqing Rural Commercial Bank Co Ltd

CRRC Corp Ltd

Circle Energy Inc

Circle Internet Group, Inc. Class A Common Stock

Circle Internet Group Inc

CENTRAL RETAIL CORP ADR by CENTRAL RETAIL CORP PUB CO LTD

California Resources Corp Warrants(27/10/2024)

Cricut Inc

Canagold Resources Ltd

The Crypto Co

Crawford & Co

CRD Network

Cardinal Ethanol LLC

Cardiff Oncology Inc

CONCORDIA FINCL UNSP/ADR by Concordia Financial Group, Ltd.

Concordia Financial Group Ltd

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

Credo Technology Group Holding Ltd - Ordinary Shares

Credo Technology Group Holding Ltd

Cerrado Gold Inc

Simplify Exchange Traded Funds Simplify Opportunistic Income ETF

COMMUNITY REDEVELOPMENT by COMMUNITY REDEVELOPMENT INC.

Community Redevelopment Inc

Carry

CREATIVE TECH LTD ORD by Creative Technology Ltd.

Creative Technology Ltd

Cream Finance

CREATIVE TECH LTD UNS/ADR by Creative Technology Ltd.

CRITICAL ELEMENTS LITHIUM by Critical Elements Lithium Corporation

Critical Elements Lithium Corp

Columbia ETF Trust I Columbia Research Enhanced Real Estate ETF

Crescera Capital Acquisition Corp lass A

Smart Powerr Corp

CRE Logistics REIT Inc

COREO AG by Coreo AG

CHINA RARE EARTH HLDGS by China Rare Earth Holdings Ltd.

China Rare Earth Holdings Ltd

Carrefour

Cresud SACIF y A

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Crescera Capital Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Carbon Revolution Public Limited Company - Ordinary Shares

Carbon Revolution PLC

Carbon Revolution Ltd Ordinary Shares

Carbon Revolution Public Limited Company - Warrant

Creative Realities Inc

Creative Realities Inc Warrants (09/11/2022)

Cornerstone Total Return Fund, Inc. (The) Common Stock

Cornerstone Total Return Fund Inc

Card Factory PLC

Zedcor Inc

BC CRAFT SUPPLY CO NEW by BC CRAFT SUPPLY CO LTD.

BC Craft Supply Co Ltd

CAREFREE GROUP INC by Carefree Group, Inc.

Carefree Group Inc

Charge Enterprises Inc

CHINA RES GAS GRP ORD by China Resources Gas Group Ltd

China Resources Gas Group Ltd

CARRIAGE HOUSE EVENT CTR by Carriage House Event Center Inc.

Carriage House Event Center Inc

Freightos Ltd

CALISSIO RES GROUP INC by Calissio Resources Group, Inc.

Calissio Resources Group Inc

Cargo Therapeutics Inc

Crescent Energy Company Class A Common Stock

Crescent Energy Co

CRH PLC

CROSS HARBOUR HLDGS LTD by Cross-Harbour Holdings Ltd.

Cross-Harbour (Holdings) Ltd

CHINA RES BEER HLDGS by China Resources Beer Holdings Company Limited

China Resources Beer (Holdings) Co Ltd

CHINA RES BEER HLDG S/ADR by China Resources Beer Holdings Company Limited

Carter's Inc

Churchill Resources Inc

Curis Inc

Exchange Traded Concepts Trust Optical Rare Earth & Critical Mats ETF

CHINA RUNJI CEMENT INC by China Runji Cement, Inc.

China Runji Cement Inc

Comstock Resources Inc

Crank Media Inc

CROWN ELECTROKINETICS CRP by Crown Electrokinetics Corp.

Crown ElectroKinetics Corp

Creek Road Miners Inc

Prairie Operating Co

CIRMAKER TECHNOLOGY CORP by Cirmaker Technology Corp.

Cirmaker Technology Corp

Charles River Laboratories International, Inc. Common Stock

Charles River Laboratories International Inc

Cresco Labs Inc

CORCEL EXPL INC by CORCEL EXPL INC

CARDINAL ENERGY LTD ORD by Cardinal Energy Ltd.

Cardinal Energy Ltd

CIRCUIT RESEARCH LABS INC by Circuit Research Labs, Inc.

CENTRAL PRKNG F/T 5.25PFD by Central Parking Finance Trust

Central Parking Financial Trust

Cerillion PLC

Salesforce Inc

WIIM

Advanced Environmental Recycling Technologies

AERT

BGLC

BGSF

BLDR

CARR

CLWT

CSWI

ELWS

EVTL

FBIN

FTAI

FWRD

HKPD

KELYB

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MVST

REZI

RKLB

RUSHA

RUSHB

SFHG

TGLS

TREX

USEA

Shares of companies in the broader industrial sector are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. This could reduce macro uncertainty that has weighed on economic outlook.

In the preceding three months, 4 analysts have released ratings for Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $171.0, with a high estimate of $200.00 and a low estimate of $144.00. Surpassing the previous average price target of $167.75, the current average has increased by 1.94%.
<img src="https://www.benzinga.com/files/images/story/2025/1746043231_0_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Crane. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$150.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$144.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Crane. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Crane compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Crane's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Crane's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Crane analyst ratings.</a>
<h2>Delving into Crane's Background</h2>
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
<h3>Understanding the Numbers: Crane's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Crane displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 43.9%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Crane's net margin is impressive, surpassing industry averages. With a net margin of 19.21%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Crane's ROE stands out, surpassing industry averages. With an impressive ROE of 6.3%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.07%, the company showcases effective utilization of assets.
Debt Management: Crane's debt-to-equity ratio is below the industry average. With a ratio of 0.14, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Breaking Down Crane: 4 Analysts Share Their Views

Stifel analyst Nathan Jones maintains Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) with a Hold and raises the price target from $144 to $150.

News

Price Target

Stifel Maintains Hold on Crane, Raises Price Target to $150

Crane shares are trading higher after the company reported better-than-expected Q1 financial results. Also, UBS upgraded the stock from Neutral to Buy and raised its price target from $157 to $190.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Rosenblatt analyst Mike Genovese upgraded the rating for Arista Networks Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) from Sell to Neutral and raised the price target from $55 to $85. Arista Networks shares closed at $78.31 on Monday. <a href="https://www.benzinga.com/quote/anet/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Damian Karas upgraded the rating for Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) from Neutral to Buy and increased the price target from $157 to $190. Crane shares closed at $148.67 on Monday. <a href="https://www.benzinga.com/quote/CR/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ANET stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-1024x584.png" alt="" class="wp-image-892707" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45060164/general-motors-coca-cola-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

ANET

VLRS

This Arista Networks Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Tuesday

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday.
Shares of Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/quote/HON/earnings">raised its FY25 adjusted EPS guidance</a>.
Revenue grew 8% year-over-year (Y/Y, organic: +4% Y/Y) to $9.82 billion, beating the consensus of $9.59 billion. Adjusted EPS was $2.51 (+7% Y/Y), beating the consensus of $2.21.
Honeywell International shares climbed 4.9% to $210.54 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) gained 21.1% to $8.81 after the company reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance.</li>
<li>Clarivate Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) jumped 16.8% to $4.1950 after the company reported better-than-expected quarterly financial results.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) jumped 16% to $24.90 as the company raised its FY2025 sales guidance.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) gained 15.7% to $22.22 following upbeat quarterly earnings.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) rose 14.8% to $9.19.</li>
<li>ProPetro Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) shares rose 11.2% to $5.86 after the company reported a first-quarter adjusted EPS and revenue beat.</li>
<li>TriMas Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRS#NYSE">TRS</a>) gained 11.2% to $23.34 following better-than-expected quarterly earnings.</li>
<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) gained 10.4% to $87.96 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 10.2% to $21.83.</li>
<li>EPWK Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) rose 9.4% to $15.00.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 7% to $96.04 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Noble Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) rose 6.4% to $22.36 after the company reported better-than-expected quarterly sales results.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) gained 5.3% to $156.47 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Intraday Update

Movers

CECO

CLVT

EPWK

FOUR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

KNSA

LZMH

MTSR

PUMP

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

UBS analyst Damian Karas upgrades Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) from Neutral to Buy and raises the price target from $157 to $190.

UBS Upgrades Crane to Buy, Raises Price Target to $190

Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) affirms FY2025 Adj EPS guidance from $5.30-$5.60 to $5.30-$5.60 vs $5.50 analyst estimate. sees sales of $2.238 billion vs $2.27 billion analyst estimate.

Guidance

Crane Sees FY 2025 Sales $2.238B vs $2.27B Est

Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) affirms FY2025 Adj EPS guidance from $5.30-$5.60 to $5.30-$5.60 vs $5.50 analyst estimate..

Crane Affirms FY2025 Adj EPS Guidance of $5.30-$5.60 vs $5.50 Est

Crane Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.31 by 6.11 percent. This is a 24.11 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $557.60 million which beat the analyst consensus estimate of $547.96 million by 1.76 percent. This is a 9.29 percent increase over sales of $510.20 million the same period last year.

Comments

Crane

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO